Musculoskeletal Pain - Pipeline Review, Q4 2010

Published by: Global Markets Direct

Published: Dec. 27, 2010 - 43 Pages


Table of Contents

Introduction
Global Markets Direct Report Coverage
Musculoskeletal Pain Overview
Therapeutics Development
An Overview of Pipeline Products for Musculoskeletal Pain
Musculoskeletal Pain Therapeutics under Development by Companies
Musculoskeletal Pain Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in Musculoskeletal Pain Therapeutics Development
Eli Lilly and Company
Taisho Pharmaceutical Co., Ltd.
ZARS Pharma, Inc.
NeuroDiscovery Ltd
Neorphys
QRxPharma Limited
Winston Pharmaceuticals, Inc.
Universities/Institutes Involved in Musculoskeletal Pain Therapeutics Development
Musculoskeletal Pain Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles - Companies
Cymbalta - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles - Universities/Institutes
Aliviador - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bupivacaine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Buprenorphine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Caffeine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fentanyl - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pioglitazone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Musculoskeletal Pain - Featured News
Nov 04, 2010: FDA Approves Cymbalta for the Management of Chronic Musculoskeletal Pain
Nov 04, 2010: Lilly's Cymbalta Wins FDA Approval For Management Of Chronic Musculoskeletal Pain
Mar 30, 2010: Lpath Rejects Merck KGaA's Proposal To Extend Opt-in Deadline
Feb 17, 2010: University Of California Presents Date From Studies Demonstrating Therapeutic Value Of Marijuana
Nov 10, 2009: Cerimon Pharmaceuticals Acquires European Rights To Topical Diclofenac Patch
Jun 03, 2009: Lilly Resubmits Cymbalta Supplemental New Drug Application For Chronic Pain To U.S. Food and Drug Administration
Feb 25, 2009: Cerimon Pharmaceuticals Initiates Phase III Clinical Studies To Evaluate Its Topical Diclofenac Sodium Patch For Mild-to-Moderate Pain
Jan 30, 2009: Eli Lilly Announces That Cymbalta Significantly Reduces Osteoarthritis Knee Pain In New Study
Sep 11, 2008: Cerimon Pharmaceuticals Announces Positive Results From A Phase II Clinical Study Of Its Diclofenac Sodium Patch For Acute Pain
May 29, 2008: Lilly Submits Cymbalta Supplemental New Drug Application For Chronic Pain to U.S. Food And Drug Administration
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products Under Development for Musculoskeletal Pain, 2010
Products under Development for Musculoskeletal Pain - Comparative Analysis, 2010
Comparative Analysis by Late Stage Development, 2010
Comparative Analysis by Mid Clinical Stage Development, 2010
Comparative Analysis by Early Clinical Stage Development, 2010
Comparative Analysis by Pre-Clinical Stage Development, 2010
Eli Lilly and Company, 2010
Taisho Pharmaceutical Co., Ltd., 2010
ZARS Pharma, Inc., 2010
NeuroDiscovery Ltd, 2010
Neorphys, 2010
QRxPharma Limited, 2010
Winston Pharmaceuticals, Inc., 2010
Assessment by Monotherapy Products, 2010
Assessment by Stage and Route of Administration, 2010
Assessment by Molecule Type, 2010
List of Figures
Number of Products under Development for Musculoskeletal Pain, 2010
Products under Development for Musculoskeletal Pain - Comparative Analysis, 2010
Products under Development by Companies, 2010
Products under Investigation by Universities/Institutes, 2010
Late Stage Products, 2010
Mid Clinical Stage Products, 2010
Early Clinical Stage Products, 2010
Pre-Clinical Stage Products, 2010
Assessment by Monotherapy Products, 2010
Assessment by Route of Administration, 2010
Assessment by Stage and Route of Administration, 2010
Assessment by Molecule Type, 2010
Assessment by Stage and Molecule Type, 2010

Abstract

Musculoskeletal Pain - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Musculoskeletal Pain    Pipeline Review, Q4 2010”, provides an overview of the Musculoskeletal Pain    therapeutic pipeline. This report provides information on the therapeutic development for Musculoskeletal Pain   , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Musculoskeletal Pain   . “Musculoskeletal Pain   -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • A snapshot of the global therapeutic scenario for Musculoskeletal Pain   .
  • A review of the Musculoskeletal Pain    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Musculoskeletal Pain    pipeline on the basis of therapeutic class, route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • A snapshot of the global therapeutic scenario for Musculoskeletal Pain   .
  • A review of the Musculoskeletal Pain    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Musculoskeletal Pain    pipeline on the basis of therapeutic class, route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.


Get full details about this report >>
 
Learn more about this product


Price and delivery options
Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.